Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/98603
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPhalke, Sameeren
dc.contributor.authorMzoughi, Slimen
dc.contributor.authorBezzi, Marcoen
dc.contributor.authorJennifer, Nancyen
dc.contributor.authorMok, Wei Chuenen
dc.contributor.authorThike, Aye Ayeen
dc.contributor.authorTan, Puay Hoonen
dc.contributor.authorVoorhoeve, P. Mathijsen
dc.contributor.authorGuccione, Ernestoen
dc.contributor.authorLow, Diana H. P.en
dc.contributor.authorKuznetsov, Vladimir A.en
dc.date.accessioned2013-07-04T02:10:25Zen
dc.date.accessioned2019-12-06T19:57:24Z-
dc.date.available2013-07-04T02:10:25Zen
dc.date.available2019-12-06T19:57:24Z-
dc.date.copyright2012en
dc.date.issued2012en
dc.identifier.citationPhalke, S., Mzoughi, S., Bezzi, M., Jennifer, N., Mok, W. C., Low, D. H. P., et al. (2012). p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Research, 40(19), 9534-9542.en
dc.identifier.issn0305-1048en
dc.identifier.urihttps://hdl.handle.net/10356/98603-
dc.description.abstractp21 is a potent cyclin-dependent kinase inhibitor that plays a role in promoting G1 cell cycle arrest and cellular senescence. Consistent with this role, p21 is a downstream target of several tumour suppressors and oncogenes, and it is downregulated in the majority of tumours, including breast cancer. Here, we report that protein arginine methyltransferase 6 (PRMT6), a type I PRMT known to act as a transcriptional cofactor, directly represses the p21 promoter. PRMT6 knock-down (KD) results in a p21 derepression in breast cancer cells, which is p53-independent, and leads to cell cycle arrest, cellular senescence and reduced growth in soft agar assays and in severe combined immunodeficiency (SCID) mice for all the cancer lines examined. We finally show that bypassing the p21-mediated arrest rescues PRMT6 KD cells from senescence, and it restores their ability to grow on soft agar. We conclude that PRMT6 acts as an oncogene in breast cancer cells, promoting growth and preventing senescence, making it an attractive target for cancer therapy.en
dc.language.isoenen
dc.relation.ispartofseriesNucleic acids researchen
dc.rights© 2012 The Author(s) (Published by Oxford University Press). This paper was published in Nucleic Acids Research and is made available as an electronic reprint (preprint) with permission of The Author(s) (Published by Oxford University Press). The paper can be found at the following official DOI: [http://dx.doi.org/10.1093/nar/gks858]. One print or electronic copy may be made for personal use only. Systematic or multiple reproduction, distribution to multiple locations via electronic or other means, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper is prohibited and is subject to penalties under law.en
dc.subjectDRNTU::Engineering::Computer science and engineeringen
dc.titlep53-independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6en
dc.typeJournal Articleen
dc.contributor.schoolSchool of Computer Engineeringen
dc.identifier.doi10.1093/nar/gks858en
dc.description.versionPublished versionen
dc.identifier.pmid22987071-
item.fulltextWith Fulltext-
item.grantfulltextopen-
Appears in Collections:SCSE Journal Articles
Files in This Item:
File Description SizeFormat 
17. P53-Independent regulation of p21Waf1.pdf4.39 MBAdobe PDFThumbnail
View/Open

SCOPUSTM   
Citations 5

84
Updated on Jun 11, 2024

Web of ScienceTM
Citations 5

77
Updated on Oct 29, 2023

Page view(s) 10

902
Updated on Jun 14, 2024

Download(s) 5

664
Updated on Jun 14, 2024

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.